Pembrolizumab-Induced Demyelinating Polyradiculoneuropathy

To the Editor: Pembrolizumab and nivolumab, two humanized antibodies against programmed cell death 1 (PD-1) receptor, were recently approved for the treatment of unresectable or metastatic melanoma and for other cancers. We report two cases of severe demyelinating polyradiculoneuropathy that…

from Melanoma via xlomafota13 on Inoreader http://ift.tt/2aejix9


from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2abklja
via IFTTT